全球乳房切片市场规模、份额、趋势和成长分析报告（2026-2034年）

预计到 2034 年，乳房切片市场规模将从 2025 年的 8.7 亿美元成长至 14 亿美元，2026 年至 2034 年的复合年增长率为 5.33%。

随着全球乳癌病例的增加，全球乳房切片市场也稳定成长。人们对早期癌症检测和定期筛检计画的意识提升是推动市场扩张的主要动力。政府和医疗机构推广乳房X光检查和诊断测试，直接增加了对切片检查的需求。微创切片检查技术和影像引导系统等技术的进步也提高了活检的安全性和准确性，鼓励更多患者选择早期诊断。

推动该市场成长的主要因素包括老年人女性人口的成长、生活方式相关的风险因素以及开发中国家医疗基础设施的改善。由于疼痛减轻和恢復时间缩短，真空抽吸活检和空芯针切片检查等先进切片检查设备正变得越来越普及。医院和诊断中心正在投资更好的影像技术以提高检测准确性。此外，已开发地区优惠的报销政策也为患者获得这些检查提供了支持。

展望未来，人工智慧 (AI) 和数位成像解决方案的融合预计将推动市场强劲成长。 AI 影像分析将帮助医生更准确、更快速地检测异常情况。在新兴经济体，不断提高的健康意识和医疗费用支出的成长可能会创造新的成长机会。对微创和快速诊断方法的持续研究将在未来几年进一步推动市场需求。

目录

第一章：引言

第二章执行摘要

第三章 市场变数、趋势与框架

• 市场谱系展望
• 渗透率和成长前景分析
• 价值链分析
• 法律规范
  • 标准与合规性
  • 监管影响分析
• 市场动态
  • 市场驱动因素
  • 市场限制因素
  • 市场机会
  • 市场挑战
• 波特五力分析
• PESTLE分析

第四章：全球乳房切片市场：依产品划分

• 市场分析、洞察与预测
• 真空抽吸切片检查
• 核心针穿刺切片
• 细针穿刺切片检查

第五章：全球乳房切片市场：依影像导引技术划分

• 市场分析、洞察与预测
• 磁振造影引导下乳房切片
• 超音波引导下乳房切片
• 乳房X光引导立体定位切片检查
• CT引导下切片检查
• 其他影像引导乳房切片

第六章 全球乳房切片市场：依最终用户划分

• 市场分析、洞察与预测
• 医院和诊所
• 诊断中心

第七章 全球乳房切片市场：按地区划分

• 区域分析
• 北美市场分析、洞察与预测
  • 我们
  • 加拿大
  • 墨西哥
• 欧洲市场分析、洞察与预测
  • 英国
  • 法国
  • 德国
  • 义大利
  • 俄罗斯
  • 其他欧洲国家
• 亚太市场分析、洞察与预测
  • 印度
  • 日本
  • 韩国
  • 澳洲
  • 东南亚
  • 其他亚太国家
• 拉丁美洲市场分析、洞察与预测
  • 巴西
  • 阿根廷
  • 秘鲁
  • 智利
  • 其他拉丁美洲国家
• 中东和非洲市场分析、洞察与预测
  • 沙乌地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中东和非洲国家

第八章 竞争情势

• 最新趋势
• 公司分类
• 供应链和销售管道合作伙伴（根据现有资讯）
• 市场占有率和市场定位分析（基于现有资讯）
• 供应商情况（基于现有资讯）
• 策略规划

第九章：公司简介

• 主要公司的市占率分析
• 公司简介
  • Ethicon Endo Surgery
  • Cook Medical Incorporated
  • Galini SRL
  • Hologic Inc
  • CR Bard Inc
  • Intact Medical Corporation
  • Becton And Dickinson Company
  • Argon Medical Devices
  • Encapsule Medical Devices LLC
  • Leica Biosystems Nussloch GmbH

The Breast Biopsy Market size is expected to reach USD 1.40 Billion in 2034 from USD 0.87 Billion (2025) growing at a CAGR of 5.33% during 2026-2034.

The Global Breast Biopsy Market is growing steadily due to the rising number of breast cancer cases worldwide. Increasing awareness about early cancer detection and regular screening programs is supporting market expansion. Governments and healthcare organizations are promoting mammography and diagnostic tests, which directly increases the demand for biopsy procedures. Technological advancements such as minimally invasive biopsy techniques and image-guided systems are also making procedures safer and more accurate, encouraging more patients to opt for early diagnosis.

The main drivers of this market include the growing female population in aging groups, lifestyle-related risk factors, and improved healthcare infrastructure in developing countries. Advanced biopsy devices like vacuum-assisted and core needle biopsy systems are gaining popularity because they reduce pain and recovery time. Hospitals and diagnostic centers are investing in better imaging technologies to improve detection accuracy. In addition, favorable reimbursement policies in developed regions are supporting patient access to these procedures.

Looking ahead, the market is expected to witness strong growth with the integration of artificial intelligence and digital imaging solutions. AI-powered imaging analysis can help doctors detect abnormalities more accurately and quickly. Emerging economies are likely to offer new growth opportunities as awareness and healthcare spending increase. Continuous research in less invasive and faster diagnostic methods will further boost market demand over the coming years.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product

• Vacuum Assisted Biopsy
• Core Needle Biopsy
• Fine Needle Aspiration Biopsy

By Image Guided Technology

• MRI Guided Breast Biopsy
• Ultrasound Guided Breast Biopsy
• Mammography Guided Stereotactic Biopsy
• CT Guided Biopsy
• Other Image Guided Breast Biopsy

By End User

• Hospitals and Clinics
• Diagnostic Centers

COMPANIES PROFILED

• Ethicon Endo Surgery, Cook Medical Incorporated, Galini SRL, Hologic Inc, C R Bard Inc, Intact Medical Corporation, Becton and Dickinson Company, Argon Medical Devices, Encapsule medical Devices LLC, Leica Biosystems Nussloch GmbH
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL BREAST BIOPSY MARKET: BY PRODUCT 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product
• 4.2. Vacuum Assisted Biopsy Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Core Needle Biopsy Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Fine Needle Aspiration Biopsy Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL BREAST BIOPSY MARKET: BY IMAGE GUIDED TECHNOLOGY 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Image Guided Technology
• 5.2. MRI Guided Breast Biopsy Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Ultrasound Guided Breast Biopsy Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Mammography Guided Stereotactic Biopsy Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. CT Guided Biopsy Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.6. Other Image Guided Breast Biopsy Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL BREAST BIOPSY MARKET: BY END USER 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast End User
• 6.2. Hospitals and Clinics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Diagnostic Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL BREAST BIOPSY MARKET: BY REGION 2022-2034(USD MN)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.2.1 By Product
  • 7.2.2 By Image Guided Technology
  • 7.2.3 By End User
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.3.1 By Product
  • 7.3.2 By Image Guided Technology
  • 7.3.3 By End User
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Russia
  • 7.3.9 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.4.1 By Product
  • 7.4.2 By Image Guided Technology
  • 7.4.3 By End User
  • 7.4.4 India
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 Australia
  • 7.4.8 South East Asia
  • 7.4.9 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.5.1 By Product
  • 7.5.2 By Image Guided Technology
  • 7.5.3 By End User
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 South East Asia
  • 7.5.9 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.6.1 By Product
  • 7.6.2 By Image Guided Technology
  • 7.6.3 By End User
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL BREAST BIOPSY INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 Ethicon Endo Surgery
  • 9.2.2 Cook Medical Incorporated
  • 9.2.3 Galini SRL
  • 9.2.4 Hologic Inc
  • 9.2.5 C. R. Bard Inc
  • 9.2.6 Intact Medical Corporation
  • 9.2.7 Becton And Dickinson Company
  • 9.2.8 Argon Medical Devices
  • 9.2.9 Encapsule Medical Devices LLC
  • 9.2.10 Leica Biosystems Nussloch GmbH